Wall Street analysts expect Zoetis Inc. (NYSE:ZTS) to report $0.63 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have issued estimates for Zoetis’ earnings. The highest EPS estimate is $0.64 and the lowest is $0.62. Zoetis reported earnings of $0.52 per share in the same quarter last year, which indicates a positive year over year growth rate of 21.2%. The business is scheduled to report its next quarterly earnings report before the market opens on Thursday, November 2nd.

On average, analysts expect that Zoetis will report full-year earnings of $2.34 per share for the current financial year, with EPS estimates ranging from $2.30 to $2.37. For the next financial year, analysts expect that the business will post earnings of $2.69 per share, with EPS estimates ranging from $2.59 to $2.74. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for Zoetis.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 8th. The company reported $0.53 EPS for the quarter, meeting the consensus estimate of $0.53. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. Zoetis had a net margin of 17.50% and a return on equity of 62.49%. The business’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the firm earned $0.49 EPS.

A number of research analysts have commented on ZTS shares. Zacks Investment Research cut shares of Zoetis from a “buy” rating to a “hold” rating in a research report on Tuesday, July 4th. Hilliard Lyons started coverage on shares of Zoetis in a research report on Tuesday, June 20th. They set a “buy” rating and a $77.00 price target on the stock. Deutsche Bank AG reiterated a “buy” rating and set a $65.00 price target (up from $62.00) on shares of Zoetis in a research report on Monday, July 17th. Stifel Nicolaus reiterated a “buy” rating and set a $65.00 price target on shares of Zoetis in a research report on Friday, September 1st. Finally, Cantor Fitzgerald set a $75.00 price target on shares of Zoetis and gave the company a “buy” rating in a research report on Monday, August 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $65.76.

Institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. lifted its position in Zoetis by 16.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after buying an additional 230 shares during the period. Harfst & Associates Inc. lifted its position in Zoetis by 16.1% during the second quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after buying an additional 260 shares during the period. Guardian Life Insurance Co. of America lifted its position in Zoetis by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,905 shares of the company’s stock valued at $102,000 after buying an additional 13 shares during the period. Almanack Investment Partners LLC. purchased a new position in Zoetis during the second quarter valued at $119,000. Finally, Point72 Asia Hong Kong Ltd purchased a new position in Zoetis during the first quarter valued at $111,000. 93.19% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This story was posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/10/17/zoetis-inc-zts-expected-to-announce-earnings-of-0-63-per-share.html.

Shares of Zoetis (ZTS) traded up 0.52% during midday trading on Tuesday, hitting $66.05. 161,673 shares of the company traded hands. The stock has a market capitalization of $32.31 billion, a PE ratio of 37.34 and a beta of 1.02. Zoetis has a 52 week low of $46.86 and a 52 week high of $66.05. The stock has a 50 day moving average of $63.94 and a 200-day moving average of $60.97.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be paid a $0.105 dividend. This represents a $0.42 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Wednesday, November 8th. Zoetis’s payout ratio is 23.73%.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Get a free copy of the Zacks research report on Zoetis (ZTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.